Volume 35, 13 February 2004 2/2004
 
  SPOT ON
 

Anti-aging with testosterone?

 
  THERAPIES FROM A CRITICAL VIEW POINT
 

Memantine (AXURA) plus donepecil (ARICEPT)?
Glycoprotein IIb/IIIa receptor antagonist needless in coronary interventions?

 
  NEW ON THE MARKET
 

Eye drops for allergic conjunctivitis: olopatadin (OPATANOL) and epinastin (RELESTAT)

 
  REVIEW
 

VValue of montelukast (SINGULAIR) in asthma

 
  ORIGINAL ARTICLE
 

How accurate are advertisements?

 
  a-t READERS' QUESTIONS AND COMMENTS
 

Clopidogrel (ISCOVER, PLAVIX): Which applications are established?

 
  IN BRIEF
 

Attention: Incorrectly low prices for simvastatine-generics
No hormon therapy for women with breast cancer
Exercise training in patients with chronic heart failure
Pancreatic carcinoma under taking ASPIRIN?

Homocysteine: Vitamins without influence on recurrent stroke

 
  SIDE EFFECTS
 

Butterbur (PETADOLEX) off market in Switzerland
Fatalities under antirheumatic drug leflunomid (ARAVA)

 
  CURRENT ADR NETWORK REPORT
 

Shock under fluoroquinolone moxifloxacine (AVALOX)

 
© arznei-telegramm 2/2004